Pimavanserin Impurity 20, identified by its CAS number 1387104-81-5, is a chemical compound that serves as an impurity associated with the pharmaceutical agent pimavanserin, which is primarily used in the treatment of Parkinson's disease psychosis. While specific characteristics such as molecular weight, structure, and solubility may not be widely documented, impurities like this one are typically characterized by their potential effects on the efficacy and safety of the primary drug. Impurities can arise during the synthesis of pharmaceuticals and may influence the pharmacokinetics and pharmacodynamics of the active ingredient. In general, impurities are assessed for their stability, reactivity, and potential toxicity. Regulatory agencies often require detailed characterization and quantification of such impurities to ensure the quality and safety of pharmaceutical products. Understanding the properties of impurities is crucial for maintaining the integrity of drug formulations and ensuring patient safety.

Pimavanserin Impurity 20

1387104-81-5: Pimavanserin Impurity 20, identified by its CAS number 1387104-81-5, is a chemical compound that serves as an impurity associated with the pharmaceutical agent pimavanserin, which is primarily used in the treatment of Parkinson's disease psychosis. While specific characteristics such as molecular weight, structure, and solubility may not be widely documented, impurities like this one are typically characterized by their potential effects on the efficacy and safety of the primary drug. Impurities can arise during the synthesis of pharmaceuticals and may influence the pharmacokinetics and pharmacodynamics of the active ingredient. In general, impurities are assessed for their stability, reactivity, and potential toxicity. Regulatory agencies often require detailed characterization and quantification of such impurities to ensure the quality and safety of pharmaceutical products. Understanding the properties of impurities is crucial for maintaining the integrity of drug formulations and ensuring patient safety.

CAS 1387104-81-5

Pimavanserin Impurity 20

Pimavanserin Impurity 20

Ref: 4Z-P-281024

Pimavanserin Impurity 52

Ref: ST-EA-CP-P112060